These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2803937)

  • 1. Response of breast carcinoma to endocrine therapy predicted using immunostained pelleted fine needle aspirates.
    Heyderman E; Ebbs SR; Larkin SE; Brown BM; Haines AM; Bates T
    Br J Cancer; 1989 Oct; 60(4):630-3. PubMed ID: 2803937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical staining of pS2 protein in fine-needle aspirate from breast cancer is an accurate guide to response to tamoxifen in patients aged over 70 years.
    Wilson YG; Rhodes M; Ibrahim NB; Padfield CJ; Cawthorn SJ
    Br J Surg; 1994 Aug; 81(8):1155-8. PubMed ID: 7953346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3H-thymidine incorporation into mammary carcinoma cells obtained by needle aspiration before and during endocrine therapy.
    Nordenskjöld B; Löwhagen T; Westerberg H; Zajicek J
    Acta Cytol; 1976; 20(2):137-43. PubMed ID: 1065173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical detection of carcinoembryonic antigen in fine-needle aspirates from patients with diverse breast diseases.
    Alexiev BA; Valkov IN; Popov AA; Marinov VS
    Diagn Cytopathol; 1993 Aug; 9(4):377-82. PubMed ID: 8261842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoperoxidase detection of carcinoembryonic antigen in fine needle aspirates of breast carcinoma. Correlation with studies in tissue sections.
    Murthy L; Kapila K; Verma K
    Acta Cytol; 1988; 32(1):60-2. PubMed ID: 3276079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of endocrine response in breast cancer by immunocytochemical detection of oestrogen receptor in fine-needle aspirates.
    Coombes RC; Powles TJ; Berger U; Wilson P; McClelland RA; Gazet JC; Trott PA; Ford HT
    Lancet; 1987 Sep; 2(8561):701-3. PubMed ID: 2888939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of hormone receptor status in fine-needle aspirates and paraffin-embedded sections from breast cancer using the novel rabbit monoclonal antibodies SP1 and SP2.
    Cano G; Milanezi F; Leitão D; Ricardo S; Brito MJ; Schmitt FC
    Diagn Cytopathol; 2003 Oct; 29(4):207-11. PubMed ID: 14506673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial markers in pancreatic carcinoma: immunoperoxidase localisation of DD9, CEA, EMA and CAM 5.2.
    Heyderman E; Larkin SE; O'Donnell PJ; Haines AM; Warren PJ; Northeast A; Grant AG
    J Clin Pathol; 1990 Jun; 43(6):448-52. PubMed ID: 1696288
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ERICA predicts response to tamoxifen in elderly women with breast cancer.
    Davies N; Moir G; Carpenter R; Cuthbert A; Herbert A; Royle GT; Taylor I
    Ann R Coll Surg Engl; 1991 Nov; 73(6):361-3. PubMed ID: 1759765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytologic examination and carcinoembryonic antigen assay of fine needle aspirates of bone tumors.
    D'Cunha S; Pinto MM
    Acta Cytol; 1994; 38(4):543-6. PubMed ID: 8042420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of S-phase fraction and ploidy in sequential fine-needle aspirates from primary human breast tumours treated with tamoxifen.
    Fernando IN; Titley JC; Powles TJ; Dowsett M; Trott PA; Ashley SE; Ford HT; Ormerod MG
    Br J Cancer; 1994 Dec; 70(6):1211-6. PubMed ID: 7981079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carcinoembryonic antigen content in fine needle aspirates of the lung. A diagnostic adjunct to cytology.
    Pinto MM; Ha DJ
    Acta Cytol; 1992; 36(3):277-82. PubMed ID: 1580109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histochemical studies of human breast cancer using a monoclonal antibody against an oestrogen receptor-related antigen.
    Hawkins RA; Sangster K; Krajewski A
    Br J Cancer; 1987 Jun; 55(6):611-6. PubMed ID: 3620302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Localization of p53 and proliferating cell nuclear antigen in fine-needle aspirates of benign and primary malignant tumors of the human breast: an immunocytochemical study using supersensitive monoclonal antibodies and the biotin-streptavidin-amplified method.
    Alexiev BA
    Diagn Cytopathol; 1996 Nov; 15(4):277-81. PubMed ID: 8982580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluorescence in situ hybridisation detection of erbB2 amplification in breast cancer fine needle aspirates.
    McManus DT; Patterson AH; Maxwell P; Humphreys MW; Anderson NH
    Mol Pathol; 1999 Apr; 52(2):75-7. PubMed ID: 10474685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunoperoxidase staining of fine needle aspiration specimens previously stained by the Papanicolaou technique.
    Travis WD; Wold LE
    Acta Cytol; 1987; 31(4):517-20. PubMed ID: 2440215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta (ER beta) level but not its ER beta cx variant helps to predict tamoxifen resistance in breast cancer.
    Esslimani-Sahla M; Simony-Lafontaine J; Kramar A; Lavaill R; Mollevi C; Warner M; Gustafsson JA; Rochefort H
    Clin Cancer Res; 2004 Sep; 10(17):5769-76. PubMed ID: 15355905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axillary lymph node metastasis: CA-15-3 and carcinoembryonic antigen concentrations in fine-needle aspirates for preoperative diagnosis in patients with breast cancer.
    Kim MJ; Park BW; Lim JB; Kim HS; Kwak JY; Kim SJ; Park SH; Sohn YM; Moon HJ; Kim EK
    Radiology; 2010 Mar; 254(3):691-7. PubMed ID: 20123899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.
    Makris A; Powles TJ; Dowsett M; Osborne CK; Trott PA; Fernando IN; Ashley SE; Ormerod MG; Titley JC; Gregory RK; Allred DC
    Clin Cancer Res; 1997 Apr; 3(4):593-600. PubMed ID: 9815725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.